Table 5 Treatment and aggressiveness of care in the re-audit period
All Patients | Treatment within last 30 days | No treatment within last 30 days | ||||
|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | |
Last treatment type | ||||||
Chemotheratpy | 47 | 6 | 13% | 41 | 87% | |
Targeted/biologic | 12 | 5 | 42% | 7 | 58% | |
Endocrine/hormonal | 6 | 2 | 33% | 4 | 67% | |
Immunotherapy | 9 | 8 | 89% | 1 | 11% | |
Treatment intent | ||||||
Curative | 6 | 8% | 1 | 5% | 5 | 9% |
Palliative | 69 | 92% | 18 | 95% | 51 | 91% |
Parameters for aggressiveness of care | ||||||
Palliative care referral | 55 | 80% | 15 | 83% | 40 | 78% |
Palliative care referral beyond last 30 days | 42 | 61% | 12 | 67% | 30 | 59% |
More than one emergency presentations | 6 | 9% | 2 | 11% | 4 | 8% |
More than one hospitalisation | 7 | 10% | 3 | 17% | 4 | 8% |
Hospitalisation 14 or more days | 15 | 22% | 4 | 22% | 11 | 22% |
ICU admission | 4 | 6% | 1 | 6% | 3 | 6% |